Ticker >

Aspira Pathlab&Diagn share price

Aspira Pathlab & Diagnostics Ltd.

BSE: 540788 SECTOR: Hospital & Healthcare Services  10k   22   1

31.28
-1.98 (-5.95%)
BSE: 12 Jun 04:01 PM

Price Summary

Today's High

₹ 35.7

Today's Low

₹ 30

52 Week High

₹ 49.5

52 Week Low

₹ 22.76

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

32.2 Cr.

Enterprise Value

30.81 Cr.

No. of Shares

1.03 Cr.

P/E

0

P/B

3.2

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  9.79

CASH

2.35 Cr.

DEBT

0.96 Cr.

Promoter Holding

18.72 %

EPS (TTM)

₹  -2.6

Sales Growth

-26.02%

ROE

-0.69 %

ROCE

2.4%

Profit Growth

-101.99 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-26.02%
3 Year19.76%
5 Year27.1%

Profit Growth

1 Year-101.99%
3 Year25.55%
5 Year14.69%

ROE%

1 Year-0.69%
3 Year21.45%
5 Year-43.5%

ROCE %

1 Year2.4%
3 Year21.85%
5 Year0.95%

Debt/Equity

0.0754

Price to Cash Flow

-2660.87

Interest Cover Ratio

0.787392138063279

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 18.72 0
Dec 2023 18.9 0
Sep 2023 18.9 0
Jun 2023 19.37 0
Mar 2023 19.47 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 19.7610201036119% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 26.5929943010209 days.
  • Company has a healthy liquidity position with current ratio of 3.69529278142352.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.21707304443175.

 Limitations

  • Company has negative cash flow from operations of -0.0121.
  • The company has a low EBITDA margin of 0.443439512030642% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 3.41 2.6 3.32 3.46 3.82
Total Expenditure 3.27 2.93 3.69 3.83 3.94
Operating Profit 0.14 -0.33 -0.37 -0.37 -0.12
Other Income 0.07 0.1 0.14 0.1 0.08
Interest 0.1 0.1 0.1 0.09 0.09
Depreciation 0.38 0.39 0.39 0.38 0.38
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.26 -0.72 -0.71 -0.74 -0.5
Tax 0 0 0 0 0
Profit After Tax -0.26 -0.72 -0.71 -0.74 -0.5
Adjusted EPS (Rs) -0.25 -0.7 -0.69 -0.72 -0.49

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 7.64 8.42 15.21 19.54 14.46
Total Expenditure 10.88 10.24 11.69 13.23 12.86
Operating Profit -3.25 -1.83 3.51 6.32 1.59
Other Income 0.25 0.29 0.2 0.15 0.32
Interest 0.96 1.01 0.89 0.37 0.42
Depreciation 1.23 1.66 1.44 1.64 1.59
Exceptional Items 0 0 0 0 0
Profit Before Tax -5.18 -4.21 1.38 4.46 -0.09
Tax 0 0.03 0 0 0
Net Profit -5.18 -4.24 1.38 4.46 -0.09
Adjusted EPS (Rs.) -6.33 -4.56 1.34 4.33 -0.09

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 8.19 9.29 10.29 10.29 10.29
Total Reserves -3 -5.49 -1.98 2.5 2.46
Borrowings 4.78 4.55 0.77 0.86 0.96
Other N/C liabilities 0.62 0.86 0.68 2.7 2.04
Current liabilities 4.21 5.12 2.01 1.79 1.58
Total Liabilities 14.8 14.34 11.78 18.14 17.34
Assets
Net Block 8.9 8.7 7.75 9.57 8.01
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.35 0.1 0.14 1.42 3.48
Other N/C Assets 3.25 2.25 0 0 0
Current Assets 2.3 3.29 3.88 7.14 5.86
Total Assets 14.8 14.34 11.78 18.14 17.34
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -5.18 -4.21 1.38 4.46 -0.09
Adjustment 1.99 2.4 2.36 2.4 1.8
Changes in Assets & Liabilities -0.19 -0.03 1.93 -4.83 -1.73
Tax Paid 0 -0.03 0 0 0
Operating Cash Flow -3.39 -1.87 5.67 2.03 -0.01
Investing Cash Flow -1.97 0.24 -0.09 -0.51 0.16
Financing Cash Flow 3.35 1.27 -2.17 -1.35 -0.94
Net Cash Flow -2 -0.35 3.41 0.17 -0.79

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 19.47 19.37 18.90 18.90 18.72
arvind karsandas bhanusha... 8.60 8.60 8.60 8.60 8.60
deepali arvind bhanushali... 8.60 8.60 8.60 8.60 8.60
paresh bhanji bhanushali 0.76 0.76 0.76 0.76 0.76
raj arvind bhanushali 0.76 0.76 0.76 0.76 0.76
geeta paresh bhanushali 0.18 0.18 0.18 0.18 -
bharat tokarshi dagha 0.57 0.47 - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 80.53 80.63 81.10 81.10 81.28
aditya agrawal 7.39 7.39 7.39 7.39 7.39
amit modi 2.92 2.92 2.92 2.92 2.92
amit modi huf 2.82 2.82 2.82 2.82 2.82
dhvani vinod bhanushali 2.91 2.91 2.91 2.91 2.91
glorious holdings pvt ltd... 7.75 7.75 7.75 6.52 5.59
jay arvind bhanushali 1.70 1.70 1.70 1.70 2.03
manas modi 3.36 3.36 3.36 3.36 3.36
manoj ramsisaria 1.99 1.99 1.99 1.99 1.99
nikunj velji mange 1.37 1.37 1.37 1.37 1.82
pankaj jashwant shah 4.86 4.86 4.86 4.86 4.86
pooja rajesh bhanushali 1.11 1.11 1.11 1.11 2.55
puspahas agrawal 2.80 2.80 2.80 2.80 2.80
rajesh premji bhanushali 1.91 1.91 1.91 1.91 3.71
ram awtar ramsisaria 2.40 2.40 2.40 2.40 2.40
rinku vinod bhanushali 8.10 8.10 8.10 8.10 8.10
saakshi gupta 1.40 1.40 1.40 1.40 1.40
shraddha jagdish bhanusha... - - - - 1.14
shradha ramsisaria 1.47 1.47 1.47 1.47 1.47
socradamus capital privat... - - - 1.22 1.22
vinod pradhan bhanushali 5.01 5.01 5.01 5.01 5.01
vinod pradhan bhanushali ... 2.91 2.91 2.91 2.91 2.91
vincent commercial 3.58 3.58 3.58 3.58 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Aspira Pathlab & Diagnostics informs about disclosure9 Apr 2024, 2:12PM Aspira Pathlab & Diagnostics informs about disclosure 19 Mar 2024, 12:25PM Aspira Pathlab & Diagnostics informs about disclosure16 Mar 2024, 12:57PM Aspira Pathlab & Diagnostics opens new Diagnostics Center in Mumbai2 Mar 2024, 12:33PM Aspira Pathlab & Diagnostics informs about disclosure2 Mar 2024, 12:13PM Aspira Pathlab&Diagn - Quaterly Results13 Feb 2024, 5:02PM Aspira Pathlab&Diagn - Quaterly Results13 Feb 2024, 5:02PM Aspira Pathlab & Diagnostics informs about closure of trading window28 Dec 2023, 5:01PM Aspira Pathlab & Diagnostics informs about newspaper publication13 Nov 2023, 12:58PM Aspira Pathlab & Diagnostics informs about change in directorate12 Aug 2023, 2:39PM Aspira Pathlab & Diagnostics informs about resignation of CS cum CO24 Jun 2023, 3:36PM Aspira Pathlab & Diagnostics informs about compliance certificate10 Apr 2023, 5:31PM Aspira Pathlab & Diagnostics informs about postal ballot voting results25 Mar 2023, 10:23AM Aspira Pathlab & Diagnostics informs about press release22 Feb 2023, 12:16PM Aspira Pathlab & Diagnostics informs about disclosure2 Jan 2023, 3:39PM Aspira Pathlab & Diagnostics informs about scrutinizer’s report and voting results12 Sep 2022, 4:36PM Aspira Pathlab & Diagnostics informs about scrutinizer's report12 Sep 2022, 4:24PM Aspira Pathlab & Diagnostics informs about newspaper publication19 Aug 2022, 4:04PM Aspira Pathlab & Diagnostics informs about disclosure4 Jul 2022, 4:23PM Aspira Pathlab & Diagnostic informs about postal ballot notice7 Jun 2022, 2:54PM Aspira Pathlab & Diagnostics informs about certificate16 Oct 2021, 12:40PM Aspira Pathlab & Diagnostics informs about resignation of CS cum CO24 Sep 2021, 10:17AM Aspira Pathlab & Diagnostics informs about AGM notice with annual report30 Aug 2021, 3:30PM Aspira Pathlab & Diagnostics informs about board meeting6 Feb 2021, 10:22AM

Aspira Pathlab&Diagn Stock Price Analysis and Quick Research Report. Is Aspira Pathlab&Diagn an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Aspira Pathlab&Diagn and its performance over the period of time. Aspira Pathlab&Diagn stock price today is Rs 31.28.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Aspira Pathlab&Diagn cash from the operating activity was Rs -0.0121 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Aspira Pathlab&Diagn has a Debt to Equity ratio of 0.0754 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Aspira Pathlab&Diagn , the EPS growth was -101.98961338719 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Aspira Pathlab&Diagn has OPM of 11.021034938334 % which is a bad sign for profitability.
     
  • ROE: Aspira Pathlab&Diagn have a poor ROE of -0.694604870065036 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Aspira Pathlab&Diagn is Rs 31.28. One can use valuation calculators of ticker to know if Aspira Pathlab&Diagn share price is undervalued or overvalued.
Last Updated on:
Brief about Aspira Pathlab&Diagn
X